Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 478-330-3 | CAS number: 95851-08-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02-04-2007 to 30-04-2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study performed under GLP. All relevant validity criteria were met.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected: August 2005; signature: November 2005
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- -
- EC Number:
- 478-330-3
- EC Name:
- -
- Cas Number:
- 95851-08-4
- Molecular formula:
- C16H32O
- IUPAC Name:
- 1-[(1R,3S,6S)-2,2,3,6-tetramethylcyclohexyl]hexan-3-ol
- Test material form:
- liquid
- Details on test material:
- - Physical state: Liquid
- Storage condition of test material: approximately 4°C in the dark
- Other: clear colourless slightly viscous liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Remarks:
- Crl : CD (SD) IGS BR
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- - Rationale for alternative/additional species to rat (if applicable): Not applicable.
- Source: Recognised supplier
- Females (if applicable) nulliparous and non-pregnant: Yes.
- Rationale for use of males (if applicable): Not applicable.
- Age at study initiation: 8 - 12 weeks.
- Weight at study initiation: 208 g (300 mg/kg including sighting test; sentinel); 200 - 244 g (2000 mg/kg sighting test; sentinel); The weight variation did not exceed ±20% of the mean weight during the test.
- Fasting period before study: Overnight before dosing and three to four hours after dosing.
- Housing: Group housed in groups of up to four in suspended solid-floor polypropylene cages furnished with woodflakes.
- Historical data: The laboratory has access to historical control data (HCD).
- Diet (e.g. ad libitum): Certified diet from recognised supplier, provided ad libitum (except for fasting period).
- Water (e.g. ad libitum): ad libitum (except for fasting period)
- Acclimation period: At least 5 days.
- Microbiological status when known: Not applicable.
- Method of randomisation in assigning animals to test and control groups: randomly allocated (not otherwise described)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25
- Humidity (%): 30 - 70%
- Air changes (per hr): > 15 air changes per hour
- Photoperiod: 12 h light / 12 h dark
IN-LIFE DATES: From: To: 2007-04-02 to 2007-04-30
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: For the purpose of the 300 mg/kg and 2000 mg/kg dose level, the test item was freshly prepared, as required, as a solution in arachis oil BP. Arachis oil BP was used because the test item did not dissolve/suspend in distilled water. The respective dose levels had the following characteristics: 300 mg/kg bw : concentration: 30 mg/mL and dose volume: 10 mL/kg ; 2000 mg/kg bw : concentration: 20 mg/mL and dose volume: 10 mL/kg
- Amount of vehicle (if gavage): Dose volumes were 10 mL/kg in vehicle
- Justification for choice of vehicle: Arachis oil BP was used because the test item did not dissolve/suspend in distilled water.
- Lot/batch no. (if required): Not reported.
- Purity: Not reported. BP grade utilised.
MAXIMUM DOSE VOLUME APPLIED: 10 mg/mL in vehicle.
DOSAGE PREPARATION (if unusual): Not applicable.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: In accordance with the OECD TG 420 guideline - Doses:
- 300 mg/kg bw (initial sighting test and main study)
2000 mg/kg bw (initial sighting test and main study) - No. of animals per sex per dose:
- 1 (sighting study) and 4 (main study) as applicable; total 5 per dose - based on guideline specified sequential testing strategy
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical observations were made 0.5, 1, 2, and 4 hours after dosing and then daily for fourteen days. Morbidity and mortality checks were made twice daily. Individual body weights were recorded on Day 0 (the day of dosing) and on Days 7 and 14.
- Necropsy of survivors performed: yes
- Clinical signs including body weight : yes. Individual body weights were recorded on Day 0 (the day of dosing) and on Days 7 and 14.
- Other examinations performed: clinical signs, body weight
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 2000 mg/kg bw (sentinel and follow-on test): No mortality
300 mg/kg bw (sentinel and definitive test): No mortality - Clinical signs:
- other: 2000 mg/kg bw (sentinel): Appeared normal throughout the study ; (follow-on test): hunched posture (5/5) and ataxia (2/5) from 4 hours until day 1. All appeared normal two days after dosing 300 mg/kg bw (sentinel and definitive test): No signs of systemic
- Gross pathology:
- 2000 mg/kg bw (sentinel and follow-on test): No abnormalities at necropsy.
300 mg/kg bw (sentinel and definitive test): No abnormalities at necropsy. - Other findings:
- - Organ weights: Not applicable.
- Histopathology: Not applicable.
- Potential target organs: Not applicable.
- Other observations: Not applicable.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study the oral LD50 was established to exceed 2000 mg/kg bw in female Sprague-Dawley CD rats. Under the conditions of this study, and according to the OECD TG 420 criteria, the LD50 cut-off value was considered to be greater than 5000 mg/kg body weight.
- Executive summary:
The study was performed according to OECD TG 420 and EU Method B.1 bis Acute Toxicity (Oral) and in accordance with GLP to assess the acute oral toxicity of the test material following a single oral administration in the female Sprague-Dawley CD strain rat by the fixed dose method. The test item was administered by oral gavage in an initial sighting study at 300 mg/kg bw within a solution of arachis oil BP vehicle. No mortality and no significant toxicity was observed. Subsequently, a further sighting at 2000 mg/kg bw in arachis oil BP vehicle was conducted, demonstrating only hunched posture which resolved by day 2. Based on no mortality and no significant toxicity being observed, a further group of four fasted females was given a single oral dose of test item at a dose level of 2000 mg/kg body weight. Clinical signs and body weight development were monitored during the study and gross necropsy performed. There was no mortality during the course of the study. Clinical signs of toxicity noted treated at a dose level of 2000 mg/kg were hunched posture (5/5) and ataxia (2/5) from 4 hours until day 1. All appeared normal two days after dosing. Animals showed expected gains in bodyweight over the study period and there were no abnormalities noted at necropsy. Under the conditions of this study the oral LD50 was established to exceed 2000 mg/kg bw in the female Wistar rat. Under the conditions of this study, and according to the OECD TG 420 criteria, the LD50 cut-off value was considered to be greater than 5000 mg/kg body weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
